Patient Monitoring Devices Market

Patient Monitoring Devices Market Size by Product (Cardiac monitoring devices, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, blood pressure monitors, ECG, ICP, weight Monitoring), User, Customer Unmet Needs & Region - Global Forecast to 2029

Report Code: MD 2436 Apr, 2024, by marketsandmarkets.com

The size of global patient monitoring Devices market in terms of revenue was estimated to be worth USD 48.5 billion in 2024 and is poised to reach USD 71.1 billion by 2029, growing at a CAGR of 8.0% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

An increase in chronic disorders and the aging population, increasing research & funding initiatives from organizations, and worldwide advancement in surgical procedures are a few drivers that collectively contribute to the growth of the Patient monitoring market, and as healthcare technological advancement continues to evolve, the demand for patient monitoring procedure is expected to rise in the forecasting years. However, challenges for high cost, stringent regulatory policies can limit the market growth.

Attractive Opportunities in the Patient Monitoring Devices Market

Patient  Monitoring Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Patient  Monitoring Devices Market

Patient Monitoring Devices Market Dynamics

Driver: Increase adoption of wireless monitoring devices

The healthcare landscape is witnessing a significant shift towards wireless monitoring devices within the broader patient monitoring market. Conventional patient monitoring methods often restrict patient mobility and comfort by tethering them to bedside equipment. Wireless devices address this limitation by facilitating greater freedom of movement, fostering a more patient-centric approach to care delivery. Wireless monitoring facilitates the continuous and real-time capture of vital signs, blood sugar levels, and other health metrics. This uninterrupted data stream offers a more holistic understanding of a patient's health compared to traditional, intermittent measurement.

Restraint: High cost of patient monitoring

Sophisticated patient monitoring systems, like hemodynamic monitors or certain wireless monitoring devices, can be expensive to purchase and install, creating a financial barrier for hospitals and healthcare facilities, particularly smaller institutions. Maintaining and upgrading patient monitoring equipment can add to the ongoing operational costs for healthcare providers. Hospital budget cuts were similar throughout Europe, and are anticipated in the upcoming years. Budget cuts have made cost-containment measures necessary in many areas of healthcare facilities.

Opportunity: Artificial Intelligence (AI) Integration - growth opportunities

Leveraging artificial intelligence (AI) empowers the analysis of vast datasets generated by patient monitoring systems. This enables real-time generation of actionable insights, facilitates predictive risk stratification, and supports the development of personalized treatment plans for improved patient outcomes. Traditionally, analyzing large datasets from patient monitoring was a time-consuming process. AI algorithms can now analyze this data in real time, identifying critical trends and potential issues as they occur.

Challenge: Technical expertise

Advanced patient monitoring systems, while generating valuable real-time vitals, waveform analysis, and trends, present a data interpretation challenge. Upskilling healthcare personnel, particularly nurses and technicians, is crucial for optimal utilization. However, time-consuming training and potential skill shortages create logistical hurdles for wider adoption in the healthcare industry.

Patient Monitoring Industry Ecosystem

Major companies in this market include well-established and financially stable suppliers of Patient monitoring. Prominent companies in this market include Medtronic plc (Ireland), GE Healthcare (US), Philips Healthcare (Netherland), Nihon Kohden Corporation (Japan), Abbott Laboratories (US), Mindray Medical International Ltd (China), Boston Scientific Corporation (US), among several others.

Patient  Monitoring Devices Market Ecosystem

Blood Glucose Monitoring Systems (BGMS) segment to register largest market share of the patient monitoring Devices industry in the year 2023.

Based on the product, the patient monitoring devices market is segmented into Blood glucose monitoring systems, Cardiac Monitoring Devices, Multi-Parameter Monitoring, Respiratory Monitoring Devices, Hemodynamic/ Pressure Monitoring Devices, Weight Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Temperature Monitoring Devices and others. BGMS segment to register largest market share in the forecast period of 2024-2029. The Blood glucose monitoring systems are further divided into self-monitoring, continuous glucose monitoring, wearable glucose monitoring. Key drivers are Advancements like continuous glucose monitoring (CGM) have revolutionized blood sugar monitoring by offering a less invasive and more convenient approach compared to traditional finger-stick methods. Furthermore, the growing number of players in the BGMS market is driving innovation and potentially lowering device costs.

Ambulatory Surgical Centers (ASCs) segment of the patient monitoring devices industry is the highest market rate end-user segment in the forecasted year 2024-2029.

The ASCs end user segment of the patient monitoring devices market registers highest market rate in the forecasted year 2024-2029. Key factors driven by Easy-to-use and portable monitoring solutions are crucial to avoid delays and optimize workflow, cost-effectiveness, workflow efficiency, and meeting the specific needs of minimally invasive procedures. Additionally, user-friendly, and delivers value without compromising patient safety. Furthermore, requiring less complex monitoring compared to major surgeries in hospitals.

Asia-Pacific is expected to be the patient monitoring devices industry highest CAGR during the forecast period.

The patient monitoring devices market is divided into key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2023, the Asia Pacific region is anticipated to exhibit the highest CAGR during the forecasting year. However, North America held the largest market share in the global Patient monitoring market. This growth is primarily attributed to the a aging population, increasing availability of advanced patient monitoring equipment like wearable devices, wireless monitors, and remote monitoring systems caters to the growing demand for these technologies in APAC countries. The APAC region is emerging as a medical tourism hub, attracting patients seeking high-quality healthcare services, including advancements in surgical techniques and the adoption of advanced Patient monitoring. Additionally, the market in the Asia Pacific region is poised for significant growth due to a combination of demographic, economic, and technological factors.

Patient  Monitoring Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

As of 2022, prominent players in the market are Medtronic plc (Ireland), GE Healthcare (US), Philips Healthcare (US), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), and Abbott Laboratories (US) among several others.

Scope of the Patient Monitoring Devices Industry

Report Metric

Details

Market Revenue in 2024

$48.5 billion

Projected Revenue by 2029

$71.1 billion

Revenue Rate

Poised to Grow at a CAGR of 8.0%

Market Driver

Increase adoption of wireless monitoring devices

Market Opportunity

Artificial Intelligence (AI) Integration - growth opportunities

This report has segmented the patient monitoring devices market to forecast revenue and analyze trends in each of the following submarkets:

BY PRODUCT (USD MILLION; 2022—2029) *

  • BLOOD GLUCOSE MONITORING SYSTEMS
    • Self-Monitoring Blood Glucose Systems
    • Continuous Glucose Monitoring Systems
    • Wearable Glucose Monitoring Systems
  • CARDIAC MONITORING DEVICES
    • ECG Devices
    • Implantable Loop Recorder
    • Event Monitors
    • MCT Monitors
    • Smart/ Wearable ECG Monitors
  • MULTI-PARAMETER MONITORING DEVICES
    • Low-Acuity Monitoring & Accessories Devices
    • Mid- Acuity Monitoring Devices
    • High- Acuity Monitoring Devices
  • RESPIRATORY MONITORING DEVICES
    • Pulse Oximeter
    • Spirometer
    • Capnographs
    • Peak Flow Meters
  • HEMODYNAMIC/ PRESSURE MONITORING DEVICES
    • Hemodynamic Monitors
    • Blood Pressure Monitors
    • Disposables
  • WEIGHT MONITORING DEVICES
    • Digital Weight Monitoring Devices
    • Analog Weight Monitoring Devices
    • Other weight monitoring devices
  • FETAL & NEONATAL MONITORING DEVICES
    • Fetal Monitoring Devices
    • Neonatal Monitoring Devices
  • NEUROMONITORING DEVICES
    • EEG Machines
    • EMG Machines
    • Cerebral Oximeters
    • ICP Monitors
    • MEG Machines
    • TCD Machines
  • TEMPERATURE MONITORING DEVICES
    • Handheld Temperature Monitoring Devices
    • Table-Top Temperature Monitoring Devices
    • Wearable Continuous Monitoring Devices
    • Invasive Temperature Monitoring Devices
    • Smart Temperature Monitoring Patches

BY END USER (USD MILLION; 2021—2029) *

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

BY REGION

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
  • MEA

Recent Market Developments of Patient Monitoring Devices Industry:

  • In 2023, GE HealthCare’s CARESCAPE Canvas Patient Monitoring Platform Received FDA Clearance.
  • In 2024, GE HealthCare received FDA clearance for an expanded indication for Novii+ maternal and fetal monitoring solution for pregnant patients ≥34 weeks.
  • In 2023, Abbott Receives FDA Clearance For Assert-IG Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 34)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
    1.6 RESEARCH LIMITATIONS 
    1.7 MARKET STAKEHOLDERS 
    1.8 SUMMARY OF CHANGES 
    1.9 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 40)
    2.1 RESEARCH DATA 
    2.2 RESEARCH DESIGN 
           2.2.1 SECONDARY RESEARCH
                    FIGURE 1 KEY DATA FROM SECONDARY SOURCES
           2.2.2 PRIMARY RESEARCH
                    2.2.2.1 Primary sources
                    2.2.2.2 Key industry insights
                    2.2.2.3 Breakdown of primaries
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION 
          FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.3.1 BOTTOM-UP APPROACH
                    2.3.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 5 PATIENT MONITORING MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
                    2.3.1.2 Approach 2: Customer-based market estimation
                                FIGURE 6 PATIENT MONITORING MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.3.2 TOP-DOWN APPROACH
                    FIGURE 7 PATIENT MONITORING MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
           2.3.3 PRIMARY INTERVIEWS
    2.4 DATA TRIANGULATION & MARKET BREAKDOWN 
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ASSESSMENT 
    2.6 STUDY ASSUMPTIONS 
    2.7 MARKET FORECASTING METHODOLOGY 
          FIGURE 9 GROWTH PROJECTIONS WERE BASED ON REVENUE IMPACT OF KEY MACROINDICATORS
    2.8 RISK ASSESSMENT 
          TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
    2.9 GROWTH RATE ASSUMPTIONS 
    2.10 RECESSION IMPACT ON PATIENT MONITORING MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 57)
    FIGURE 10 PATIENT MONITORING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    FIGURE 11 PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    FIGURE 12 GEOGRAPHICAL SNAPSHOT OF PATIENT MONITORING MARKET
 
4 PREMIUM INSIGHTS (Page No. - 60)
    4.1 PATIENT MONITORING MARKET OVERVIEW 
          FIGURE 13 GROWING ADOPTION OF WIRELESS MONITORING DEVICES TO DRIVE MARKET GROWTH
    4.2 PATIENT MONITORING MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 
          FIGURE 14 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.3 PATIENT MONITORING MARKET, BY REGION AND END USER, 2023 (USD MILLION) 
          FIGURE 15 HOSPITALS & CLINICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.4 GEOGRAPHIC SNAPSHOT OF PATIENT MONITORING MARKET 
          FIGURE 16 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 64)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 17 PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Emergence of predictive analytics in vital sign monitors
                    5.2.1.2 Growing preference for wearable patient monitoring devices, biosensors, and smart implants
                    5.2.1.3 Availability of wireless monitoring devices
                    5.2.1.4 Expansion of telehealth services and remote monitoring capabilities
                    5.2.1.5 Growing incidence of chronic diseases
           5.2.2 RESTRAINTS
                    5.2.2.1 Risks associated with invasive monitoring devices
                    5.2.2.2 High cost of patient monitoring products and inadequate reimbursement
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Integration with electronic health records (EHRs)
                    5.2.3.2 Expansion of remote patient monitoring in home healthcare settings
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of personnel and limited awareness & education for patient monitoring devices
                    5.2.4.2 Increased pricing pressure on market players
    5.3 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 2 PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 REGULATORY ANALYSIS 
          TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 6 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
          TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.5 KEY REGULATORY GUIDELINES 
           5.5.1 NORTH AMERICA
                    5.5.1.1 US
                                TABLE 8 US: CLASSIFICATION OF MEDICAL EQUIPMENT
                                TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.5.1.2 Canada
                                TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.5.2 EUROPE
                    TABLE 11 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.5.3 ASIA PACIFIC
                    5.5.3.1 Japan
                                TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.5.3.2 India
                    5.5.3.3 China
    5.6 REIMBURSEMENT SCENARIO 
          TABLE 13 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
    5.7 ECOSYSTEM ANALYSIS 
    5.8 KEY MARKET PLAYERS IN PATIENT MONITORING MARKET 
    5.9 INVESTMENT & FUNDING SCENARIO 
          FIGURE 18 NUMBER OF INVESTOR DEALS IN PATIENT MONITORING MARKET, BY KEY PLAYER, 2018–2022
          FIGURE 19 VALUE OF INVESTOR DEALS IN PATIENT MONITORING MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
    5.10 TECHNOLOGY ANALYSIS 
           5.10.1 KEY TECHNOLOGIES
                    5.10.1.1 Smart wearable monitoring devices
                    5.10.1.2 Vital sign monitors
           5.10.2 COMPLEMENTARY TECHNOLOGIES
                    5.10.2.1 Remote patient monitors
                    5.10.2.2 AI & IoT
                    5.10.2.3 Telehealth
           5.10.3 ADJACENT TECHNOLOGIES
                    5.10.3.1 IVD
                    5.10.3.2 Medical imaging
    5.11 VALUE CHAIN ANALYSIS 
           5.11.1 RESEARCH & DEVELOPMENT
           5.11.2 PROCUREMENT AND PRODUCT DEVELOPMENT
           5.11.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
                     FIGURE 20 PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
    5.12 SUPPLY CHAIN ANALYSIS 
           5.12.1 PROMINENT COMPANIES
           5.12.2 SMALL & MEDIUM-SIZED COMPANIES
           5.12.3 END USERS
                     FIGURE 21 PATIENT MONITORING MARKET: SUPPLY CHAIN ANALYSIS
    5.13 PRICING ANALYSIS 
           FIGURE 22 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY PRODUCT (FY 2021–2023)
           FIGURE 23 AVERAGE SELLING PRICE TREND OF PATIENT MONITORING DEVICES, BY REGION, 2021–2023 (USD)
    5.14 PATENT ANALYSIS 
           FIGURE 24 PATENT DETAILS FOR PATIENT MONITORING DEVICES (JANUARY 2013–DECEMBER 2023)
    5.15 TRADE ANALYSIS 
           TABLE 14 IMPORT DATA FOR PATIENT MONITORING DEVICES (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
           TABLE 15 EXPORT DATA FOR PATIENT MONITORING DEVICES (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
    5.16 KEY CONFERENCES & EVENTS, 2024–2025 
           TABLE 16 PATIENT MONITORING MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2024–2025
    5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 25 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
    5.18 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     TABLE 17 KEY REQUIREMENTS OF DEPARTMENTS/STAKEHOLDERS WHILE BUYING PATIENT MONITORING DEVICES
           5.18.2 BUYING CRITERIA
                     FIGURE 26 BUYING CRITERIA
                     FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES
                     TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
    5.19 PATIENT MONITORING MARKET: RECESSION IMPACT 
    5.20 UNMET NEEDS & KEY PAIN POINTS 
           TABLE 19 PATIENT MONITORING MARKET: UNMET CUSTOMER NEEDS & KEY PAIN POINTS
 
6 PATIENT MONITORING MARKET, BY PRODUCT (Page No. - 100)
    6.1 INTRODUCTION 
          TABLE 20 PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
    6.2 BLOOD GLUCOSE MONITORING DEVICES 
          TABLE 21 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 22 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 23 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.2.1 SELF-MONITORING BLOOD GLUCOSE DEVICES
                    6.2.1.1 Rising adoption of integrated glucose monitoring devices to drive growth
                                 TABLE 24 SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.2 CONTINUOUS GLUCOSE MONITORING DEVICES
                    6.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring devices to drive market growth
                                 TABLE 25 CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.3 WEARABLE GLUCOSE MONITORING DEVICES
                    6.2.3.1 Growing patient inclination towards wearable monitors to boost market
                                 TABLE 26 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.3 CARDIAC MONITORING DEVICES 
          TABLE 27 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 28 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 29 CARDIAC MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.3.1 ECG DEVICES
                    6.3.1.1 Low cost and wide applications of ECG devices to drive market growth
                                 TABLE 30 ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.2 IMPLANTABLE LOOP RECORDERS (ILRS)
                    6.3.2.1 High cost and limited applications to limit growth
                                 TABLE 31 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.3 EVENT MONITORS
                    6.3.3.1 Emergence of portable and wireless event monitors to drive market growth
                                 TABLE 32 EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.4 MCT MONITORS
                    6.3.4.1 Availability of alternate technologies to hinder market growth
                                 TABLE 33 MCT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.5 SMART/WEARABLE ECG MONITORS
                    6.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors
                                 TABLE 34 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS
                                 TABLE 35 SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.4 MULTIPARAMETER MONITORING DEVICES 
          TABLE 36 MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 37 MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 38 MULTIPARAMETER MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.4.1 LOW-ACUITY MONITORS
                    6.4.1.1 Increasing adoption of low-acuity monitors in general wards to drive market growth
                                 TABLE 39 LOW-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.2 MID-ACUITY MONITORS
                    6.4.2.1 Rising geriatric population to increase market growth
                                 TABLE 40 MID-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.3 HIGH-ACUITY MONITORS
                    6.4.3.1 Increasing partnerships between manufacturers and hospitals & clinics to drive device sales
                                 TABLE 41 HIGH-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.5 RESPIRATORY MONITORING DEVICES 
          TABLE 42 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 43 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 44 RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.5.1 PULSE OXIMETERS
                    6.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth
                                 TABLE 45 PULSE OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.2 SPIROMETERS
                    6.5.2.1 Technological advancements to increase adoption of spirometers
                                 TABLE 46 SPIROMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.3 CAPNOGRAPHS
                    6.5.3.1 Product development and growing commercial acceptance to drive market growth
                                 TABLE 47 CAPNOGRAPHS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.4 PEAK FLOW METERS
                    6.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices to hinder market growth
                                 TABLE 48 PEAK FLOW METERS MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.6 TEMPERATURE MONITORING DEVICES 
          TABLE 49 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 50 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 51 TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.6.1 HANDHELD TEMPERATURE MONITORING DEVICES
                    6.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth
                                 TABLE 52 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS
                                 TABLE 53 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
                    6.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for TABLE-top devices
                                 TABLE 54 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.6.3 WEARABLE CONTINUOUS MONITORING DEVICES
                    6.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand
                                 TABLE 55 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS
                                 TABLE 56 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.6.4 INVASIVE TEMPERATURE MONITORING DEVICES
                    6.6.4.1 Risk of bloodstream infections associated with catheter usage to hinder market for invasive devices
                                 TABLE 57 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.6.5 SMART TEMPERATURE MONITORING PATCHES
                    6.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth
                                 TABLE 58 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS
                                 TABLE 59 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES 
          TABLE 60 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 61 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 62 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.7.1 HEMODYNAMIC MONITORS
                    6.7.1.1 Influx of VC funding to drive market growth
                                 TABLE 63 HEMODYNAMIC MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.7.2 BLOOD PRESSURE MONITORS
                    6.7.2.1 Development of wearable blood pressure monitors to drive market growth
                                 TABLE 64 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS
                                 TABLE 65 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.7.3 DISPOSABLES
                    6.7.3.1 Growing number of surgical procedures to drive growth in disposables market
                                 TABLE 66 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.8 FETAL & NEONATAL MONITORING DEVICES 
TABLE 67 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 68 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 69 FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.8.1 FETAL MONITORING DEVICES
                    6.8.1.1 Rising prevalence of obstetric complications to drive market growth
                                 TABLE 70 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS
                                 TABLE 71 FETAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.8.2 NEONATAL MONITORING DEVICES
                    6.8.2.1 Rising number of neonatal care facilities worldwide to drive market
                                 TABLE 72 NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.9 NEUROMONITORING DEVICES 
TABLE 73 NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 74 NEUROMONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 75 NEUROMONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.9.1 EEG MACHINES
                    6.9.1.1 Growing applications and technological advancements to favor market growth
                                 TABLE 76 EEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.9.2 EMG MACHINES
                    6.9.2.1 Availability of reimbursements for EMG-assisted surgeries to boost product demand
                                 TABLE 77 EMG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.9.3 CEREBRAL OXIMETERS
                    6.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth
                                 TABLE 78 CEREBRAL OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.9.4 ICP MONITORS
                    6.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs to support adoption of ICP monitors
                                 TABLE 79 ICP MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.9.5 MEG MACHINES
                    6.9.5.1 High implementation and maintenance costs of MEG devices to hinder market growth
                                 TABLE 80 MEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.9.6 TCD MACHINES
                    6.9.6.1 Rising prevalence of strokes and cerebrovascular disorders to contribute to market growth
                                 TABLE 81 TCD MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.10 WEIGHT MONITORING DEVICES 
           TABLE 82 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           TABLE 83 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           TABLE 84 WEIGHT MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
           6.10.1 DIGITAL WEIGHT MONITORING DEVICES
                    6.10.1.1 Consumer preference for digital scales—a key market driver
                                 TABLE 85 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.10.2 ANALOG WEIGHT MONITORING DEVICES
                    6.10.2.1 Rising prevalence of obesity and low cost of analog scales to support market growth
                                 TABLE 86 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.11 OTHER PATIENT MONITORING DEVICES 
           TABLE 87 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS
           TABLE 88 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS
           TABLE 89 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
           TABLE 90 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
7 PATIENT MONITORING MARKET, BY END USER (Page No. - 156)
    7.1 INTRODUCTION 
          TABLE 91 PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
    7.2 HOSPITALS & CLINICS 
           7.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF PATIENT MONITORING TECHNOLOGIES TO BOOST MARKET
                    TABLE 92 PATIENT MONITORING MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 93 PATIENT MONITORING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
    7.3 AMBULATORY SURGICAL CENTERS 
           7.3.1 COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE DEMAND FOR AMBULATORY CARE
                    TABLE 94 PATIENT MONITORING MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022–2029 (USD MILLION)
    7.4 HOME CARE SETTINGS 
           7.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH
                    TABLE 95 PATIENT MONITORING MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION)
    7.5 OTHER END USERS 
          TABLE 96 PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
 
8 PATIENT MONITORING MARKET, BY REGION (Page No. - 162)
    8.1 INTRODUCTION 
          TABLE 97 PATIENT MONITORING MARKET, BY REGION, 2022–2029 (USD MILLION)
    8.2 NORTH AMERICA 
          FIGURE 28 NORTH AMERICA: PATIENT MONITORING MARKET SNAPSHOT
          TABLE 98 NORTH AMERICA: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 99 NORTH AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 100 NORTH AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 101 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 102 NORTH AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 103 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 104 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 105 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 106 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 107 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 108 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 109 NORTH AMERICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
           8.2.1 NORTH AMERICA: RECESSON IMPACT
           8.2.2 US
                    8.2.2.1 Growing number of FDA approvals for patient monitoring devices to support market growth
                                TABLE 110 VC FUNDING IN PATIENT MONITORING MARKET IN US
                                TABLE 111 US: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 112 US: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 113 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 114 US: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 115 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 116 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 117 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 118 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 119 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 120 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.2.3 CANADA
                    8.2.3.1 Growing public-private funding for research to drive market growth
                                TABLE 121 RESEARCH GRANTS IN PATIENT MONITORING MARKET IN CANADA
                                TABLE 122 RECENT DEVELOPMENTS IN CANADIAN PATIENT MONITORING MARKET
                                TABLE 123 CANADA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 124 CANADA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 125 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 126 CANADA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 127 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 128 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 129 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 130 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 131 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 132 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
    8.3 EUROPE 
          TABLE 133 PRODUCT APPROVALS IN EUROPEAN PATIENT MONITORING MARKET
          TABLE 134 EUROPE: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 135 EUROPE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 136 EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 137 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 138 EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 139 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 140 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 141 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 142 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 143 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 144 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 145 EUROPE: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
           8.3.1 EUROPE: RECESSION IMPACT
           8.3.2 GERMANY
                    8.3.2.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
                                TABLE 146 GERMANY: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 147 GERMANY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 148 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 149 GERMANY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 150 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 151 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 152 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 153 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 154 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 155 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.3.3 UK
                    8.3.3.1 Increasing public & private investments to contribute to market growth
                                TABLE 156 UK: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 157 UK: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 158 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 159 UK: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 160 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 161 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 162 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 163 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 164 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 165 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.3.4 FRANCE
                    8.3.4.1 Statutory health insurance system to support market growth
                                TABLE 166 FRANCE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 167 FRANCE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 168 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 169 FRANCE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 170 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 171 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 172 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 173 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 174 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 175 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.3.5 ITALY
                    8.3.5.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices
                                TABLE 176 ITALY: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 177 ITALY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 178 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 179 ITALY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 180 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 181 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 182 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 183 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 184 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 185 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.3.6 SPAIN
                    8.3.6.1 Growing number of surgical procedures to drive market growth in Spain
                                TABLE 186 SPAIN: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 187 SPAIN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 188 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 189 SPAIN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 190 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 191 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 192 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 193 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 194 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 195 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.3.7 REST OF EUROPE
                    TABLE 196 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN PATIENT MONITORING MARKET IN ROE
                    TABLE 197 REST OF EUROPE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 198 REST OF EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 199 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 200 REST OF EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 201 REST OF EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 202 REST OF EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 203 REST OF EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 204 REST OF EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 205 REST OF EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 206 REST OF EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
    8.4 ASIA PACIFIC 
          FIGURE 29 ASIA PACIFIC: PATIENT MONITORING MARKET SNAPSHOT
          TABLE 207 ASIA PACIFIC: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 208 ASIA PACIFIC: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 209 ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 210 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 211 ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 212 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 213 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 214 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 215 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 216 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 217 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 218 ASIA PACIFIC: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
           8.4.1 ASIA PACIFIC: RECESSION IMAPCT
           8.4.2 JAPAN
                    8.4.2.1 Large geriatric population and favorable reimbursement scenario to support market growth
                                TABLE 219 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN JAPAN
                                TABLE 220 JAPAN: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 221 JAPAN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 222 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 223 JAPAN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 224 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 225 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 226 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 227 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 228 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 229 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.4.3 CHINA
                    8.4.3.1 Growing focus of local and international market players to favor market growth
                                TABLE 230 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN CHINA
                                TABLE 231 CHINA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 232 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 233 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 234 CHINA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 235 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 236 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 237 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 238 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 239 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 240 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.4.4 INDIA
                    8.4.4.1 Increasing government-implemented healthcare initiatives to support market growth
                                TABLE 241 INDIA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 242 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 243 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 244 INDIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 245 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 246 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 247 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 248 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 249 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 250 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.4.5 AUSTRALIA
                    8.4.5.1 R&D Tax Incentive Program to support market growth
                                TABLE 251 AUSTRALIA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 252 AUSTRALIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 253 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 254 AUSTRALIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 255 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 256 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 257 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 258 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 259 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 260 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.4.6 SOUTH KOREA
                    8.4.6.1 Supportive government initiatives to drive market growth
                                TABLE 261 SOUTH KOREA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 262 SOUTH KOREA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 263 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 264 SOUTH KOREA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 265 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 266 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 267 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 268 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 269 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 270 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.4.7 REST OF ASIA PACIFIC
                    TABLE 271 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN ROAPAC
                    TABLE 272 REST OF ASIA PACIFIC: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 273 REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 274 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 275 REST OF ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 276 REST OF ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 277 REST OF ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 278 REST OF ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 279 REST OF ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 280 REST OF ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 281 REST OF ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
    8.5 LATIN AMERICA 
          TABLE 282 LATIN AMERICA: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 283 LATIN AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 284 LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 285 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 286 LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 287 LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 288 LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 289 LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 290 LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 291 LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 292 LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 293 LATIN AMERICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
           8.5.1 LATIN AMERICA: RECESSION IMAPCT
           8.5.2 BRAZIL
                    8.5.2.1 Brazil to dominate LATAM market
                                TABLE 294 BRAZIL: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 295 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 296 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 297 BRAZIL: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 298 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 299 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 300 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 301 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 302 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 303 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.5.3 MEXICO
                    8.5.3.1 Favorable investment scenario for medical device manufacturers to drive market growth
                                TABLE 304 MEXICO: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 305 MEXICO: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 306 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 307 MEXICO: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 308 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 309 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 310 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 311 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 312 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 313 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
           8.5.4 REST OF LATIN AMERICA
                    TABLE 314 REST OF LATIN AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 315 REST OF LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 316 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 317 REST OF LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 318 REST OF LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 319 REST OF LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 320 REST OF LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 321 REST OF LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 322 REST OF LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 323 REST OF LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
    8.6 MIDDLE EAST & AFRICA 
           8.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES IN REGION
                    TABLE 324 MIDDLE EAST & AFRICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 325 MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 326 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 327 MIDDLE EAST & AFRICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 328 MIDDLE EAST & AFRICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 329 MIDDLE EAST & AFRICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 330 MIDDLE EAST & AFRICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 331 MIDDLE EAST & AFRICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 332 MIDDLE EAST & AFRICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 333 MIDDLE EAST & AFRICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 334 MIDDLE EAST & AFRICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
           8.6.2 MIDDLE EAST & AFRICA: RECESSION IMAPCT
 
9 COMPETITIVE LANDSCAPE (Page No. - 297)
    9.1 OVERVIEW 
    9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
           9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PATIENT MONITORING PLAYERS
    9.3 REVENUE ANALYSIS 
          FIGURE 30 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT MONITORING MARKET, 2019–2023 (USD MILLION)
    9.4 MARKET SHARE ANALYSIS 
           9.4.1 GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
                    FIGURE 31 BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
           9.4.2 GLOBAL CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
                    FIGURE 32 CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
           9.4.3 GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
                    FIGURE 33 MULTIPARAMETER MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
           9.4.4 GLOBAL HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
                    FIGURE 34 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
           9.4.5 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
                    FIGURE 35 FETAL & NEONATAL MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
                    TABLE 335 PATIENT MONITORING MARKET: DEGREE OF COMPETITION
    9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 
           9.5.1 STARS
           9.5.2 EMERGING LEADERS
           9.5.3 PERVASIVE PLAYERS
           9.5.4 PARTICIPANTS
                    FIGURE 36 PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
           9.5.5 COMPANY FOOTPRINT: KEY PLAYERS
                    FIGURE 37 COMPANY FOOTPRINT (15 COMPANIES)
                    TABLE 336 PRODUCT FOOTPRINT (15 COMPANIES)
                    TABLE 337 REGIONAL FOOTPRINT (15 COMPANIES)
    9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 
           9.6.1 PROGRESSIVE COMPANIES
           9.6.2 RESPONSIVE COMPANIES
           9.6.3 DYNAMIC COMPANIES
           9.6.4 STARTING BLOCKS
                    FIGURE 38 PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
           9.6.5 COMPETITIVE BENCHMARKING
                    TABLE 338 PATIENT MONITORING MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS
                    TABLE 339 PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
    9.7 COMPETITIVE SCENARIO 
           9.7.1 PRODUCT LAUNCHES & APPROVALS
                    TABLE 340 PATIENT MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–OCTOBER 2023
           9.7.2 DEALS
                    TABLE 341 PATIENT MONITORING MARKET: DEALS, JANUARY 2021–FEBRUARY 2024
    9.8 COMPANY VALUATION & FINANCIAL METRICS 
          FIGURE 39 EV/EBITDA OF KEY VENDORS
          FIGURE 40 5-YEAR STOCK BETA OF KEY VENDORS
    9.9 PRODUCT/BRAND COMPARISON 
          FIGURE 41 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023)
 
10 COMPANY PROFILES (Page No. - 316)
     10.1 KEY PLAYERS 
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
             10.1.1 MEDTRONIC PLC
                        TABLE 342 MEDTRONIC PLC: COMPANY OVERVIEW
                        FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
                        TABLE 343 MEDTRONIC PLC: PRODUCTS OFFERED
                        TABLE 344 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS
                        TABLE 345 MEDTRONIC PLC: DEALS
             10.1.2 ABBOTT LABORATORIES
                        TABLE 346 ABBOTT LABORATORIES: COMPANY OVERVIEW
                        FIGURE 43 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
                        TABLE 347 ABBOTT LABORATORIES: PRODUCTS OFFERED
                        TABLE 348 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS
                        TABLE 349 ABBOTT LABORATORIES: DEALS
             10.1.3 DEXCOM, INC.
                        TABLE 350 DEXCOM, INC.: COMPANY OVERVIEW
                        FIGURE 44 DEXCOM, INC.: COMPANY SNAPSHOT (2023)
                        TABLE 351 DEXCOM, INC.: PRODUCTS OFFERED
                        TABLE 352 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS
             10.1.4 GE HEALTHCARE
                        TABLE 353 GE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 45 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
                        TABLE 354 GE HEALTHCARE: PRODUCTS OFFERED
                        TABLE 355 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
                        TABLE 356 GE HEALTHCARE: DEALS
             10.1.5 PHILIPS HEALTHCARE
                        TABLE 357 PHILIPS HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 46 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023)
                        TABLE 358 PHILIPS HEALTHCARE: PRODUCTS OFFERED
                        TABLE 359 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
                        TABLE 360 PHILIPS HEALTHCARE: DEALS
             10.1.6 NIHON KOHDEN CORPORATION
                        TABLE 361 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
                        FIGURE 47 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 362 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
                        TABLE 363 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS
             10.1.7 MINDRAY MEDICAL INTERNATIONAL LTD.
                        TABLE 364 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY OVERVIEW
                        FIGURE 48 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY SNAPSHOT (2022)
                        TABLE 365 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCTS OFFERED
                        TABLE 366 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCT LAUNCHES & APPROVALS
                        TABLE 367 MINDRAY MEDICAL INTERNATIONAL LTD.: DEALS
             10.1.8 EDWARDS LIFESCIENCES CORPORATION
                        TABLE 368 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
                        FIGURE 49 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 369 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
             10.1.9 GETINGE AB
                        TABLE 370 GETINGE AB: COMPANY OVERVIEW
                        FIGURE 50 GETINGE AB.: COMPANY SNAPSHOT (2023)
                        TABLE 371 GETINGE AB: PRODUCTS OFFERED
                        TABLE 372 GETINGE AB: PRODUCT LAUNCHES & APPROVALS
                        TABLE 373 GETINGE AB: DEALS
             10.1.10 BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC.)
                        TABLE 374 BAXTER INTERNATIONAL: COMPANY OVERVIEW
                        FIGURE 51 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2023)
                        TABLE 375 BAXTER INTERNATIONAL: PRODUCTS OFFERED
                        TABLE 376 BAXTER INTERNATIONAL: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
                        TABLE 377 BAXTER INTERNATIONAL: DEALS
             10.1.11 DRÄGERWERK AG & CO. KGAA
                        TABLE 378 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
                        FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
                        TABLE 379 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED
             10.1.12 BOSTON SCIENTIFIC CORPORATION
                        TABLE 380 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
                        FIGURE 53 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 381 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
                        TABLE 382 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS
                        TABLE 383 BOSTON SCIENTIFIC CORPORATION: DEALS
             10.1.13 MASIMO CORPORATION
                        TABLE 384 MASIMO CORPORATION: COMPANY OVERVIEW
                        FIGURE 54 MASIMO CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 385 MASIMO CORPORATION: PRODUCTS OFFERED
                        TABLE 386 MASIMO CORPORATION: PRODUCT LAUNCHES & APPROVALS
                        TABLE 387 MASIMO CORPORATION: DEALS
             10.1.14 OMRON CORPORATION
                        TABLE 388 OMRON CORPORATION: COMPANY OVERVIEW
                        FIGURE 55 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 389 OMRON CORPORATION: PRODUCTS OFFERED
                        TABLE 390 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS
                        TABLE 391 OMRON CORPORATION: DEALS
             10.1.15 ARCHIMED SAS (NATUS MEDICAL)
                        TABLE 392 ARCHIMED SAS (NATUS MEDICAL): BUSINESS OVERVIEW
                        TABLE 393 ARCHIMED SAS (NATUS MEDICAL): PRODUCTS OFFERED
                        TABLE 394 ARCHIMED SAS (NATUS MEDICAL): DEALS
             10.1.16 COMPUMEDICS LIMITED
                        TABLE 395 COMPUMEDICS LIMITED: BUSINESS OVERVIEW
                        FIGURE 56 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2023)
                        TABLE 396 COMPUMEDICS LIMITED: PRODUCTS OFFERED
                        TABLE 397 COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS
                        TABLE 398 COMPUMEDICS LIMITED: DEALS
             10.1.17 NONIN MEDICAL, INC.
                        TABLE 399 NONIN MEDICAL, INC.: BUSINESS OVERVIEW
                        TABLE 400 NONIN MEDICAL, INC.: PRODUCTS OFFERED
                        TABLE 401 NONIN MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS
     10.2 OTHER PLAYERS 
             10.2.1 BIOTRONIK
             10.2.2 SCHILLER AG
             10.2.3 SENSEONICS
             10.2.4 CARDIOMO
             10.2.5 VITLS
             10.2.6 NETEERA
             10.2.7 QARDIO
             10.2.8 VIVIFY HEALTH
             10.2.9 IRHYTHM TECHNOLOGIES, INC.
             10.2.10 OSYPKA MEDICAL
             10.2.11 CARDINAL HEALTH
             10.2.12 MERIT MEDICAL SYSTEMS
 
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
 
11 APPENDIX (Page No. - 398)
     11.1 DISCUSSION GUIDE 
     11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     11.3 CUSTOMIZATION OPTIONS 
     11.4 RELATED REPORTS 
     11.5 AUTHOR DETAILS 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Patient monitoring market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in product therapy markets. The primary sources from the demand side include medical OEMs, Analytical instrument OEMs, CDMOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Patient  Monitoring Devices Market Size, and Share

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

In this report, the patient monitoring market size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the patient monitoring market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involved the following steps:

  • Generating a list of major global players operating in the patient monitoring market.
  • Mapping annual revenues generated by major global players from the patient monitoring market(or nearest reported business unit/product category).
  • Revenue mapping of key players to cover a major share of the global market, as of 2022
  • Extrapolating the global value of the patient monitoring market.

Global Patient Monitoring Market: Bottom-Up Approach

Patient  Monitoring Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Patient Monitoring Market : Top-Down Approach

Patient  Monitoring Devices Market Size, and Share

Patient  Monitoring Devices Market Size, and Share

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the patient monitoring market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the patient monitoring market was validated using both top-down and bottom-up approaches.

Market Definition

Patient monitoring involves continuously or intermittently observing and evaluating a patient's physiological parameters, vital signs, and clinical condition to track their health status and response to medical treatment. This process utilizes various medical devices and technologies to measure and track parameters such as heart rate, blood pressure, oxygen saturation, respiratory rate, temperature, and electrocardiography (ECG) readings. Modern patient monitoring systems utilize advanced medical devices, sensors, telemetry systems, and software platforms to capture, display, analyze, and transmit patient data in real-time.

Key Stakeholders

  • Manufacturers and distributors of patient monitoring devices
  • Healthcare institutions (Hospitals and clinics)
  • Ambulatory surgical centers
  • Healthcare institutions (hospitals and cardiac centers)
  • Research institutions
  • Research and consulting firms
  • Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
  • Academic medical centers and universities
  • Market research and consulting firms
  • Clinical research organizations
  • Ambulatory Surgery Centers
  • Group Purchasing Organizations (GPOs)
  • Medical Research Laboratories
  • Academic Medical Centers and Universities
  • Accountable Care Organizations (ACOs)

Objectives of the Study

  • To define, describe, and forecast the patient monitoring market on Product and end user.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).
  • To strategically analyze the micro markets concerning individual growth trends, prospects, and contributions to the total market.
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To profile the key market players and comprehensively analyze their market shares and core competencies.
  • To forecast the revenue of the market segments concerning five main regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
  • To track and analyze competitive developments such as new product launches and approvals; agreements, partnerships, expansions, acquisitions; and collaborations in the patient monitoring market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global patient monitoring market

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top thirteen companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to 15)

Geographic Analysis

  • Further breakdown of the Rest of Europe's patient monitoring market Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal among other
  • Further breakdown of the Rest of Asia Pacific patient monitoring market Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of the world patient monitoring market Latin America, MEA, and Africa
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 2436
Published ON
Apr, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Patient Monitoring Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback